お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:北米のニードルフリー注射器市場の将来展望
市場調査レポート
商品コード
537188

北米のニードルフリー注射器市場の将来展望

North America Needle Free Injections Market Outlook to 2023

出版日: | 発行: GlobalData | ページ情報: 英文 95 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.20円
北米のニードルフリー注射器市場の将来展望
出版日: 2017年08月01日
発行: GlobalData
ページ情報: 英文 95 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、北米諸国におけるニードルフリー注射器 (無針注射器) の市場について分析し、全体的な市場動向の推移や見通し (過去・今後8年間分)、各国市場の詳細動向、主要企業・流通チャネルの市場シェア、主なパイプライン製品の現在の治験状況、昨今の事業展開の動き、主要企業のプロファイルなどについて調査しております。

第1章 目次

第2章 イントロダクション

  • 当レポートの概要
  • ニードルフリー注射器市場の分類
  • 分析対象の定義

第3章 北米のニードルフリー注射器市場

  • 市場収益額:金額ベース (通算15年間分)
  • 市場収益額の実績値:金額ベース (過去8年間分)
  • 市場収益額の予測値:金額ベース (今後8年間分)
  • 市場規模:数量ベース (通算15年間分)
  • 市場規模の実績値:数量ベース (過去8年間分)
  • 市場規模の予測値:数量ベース (今後8年間分)
  • 市場収益額シェア:企業別

第4章 カナダのニードルフリー注射器市場

  • 市場収益額の実績値:金額ベース (過去8年間分)
  • 市場収益額の予測値:金額ベース (今後8年間分)
  • 市場規模の実績値:数量ベース (過去8年間分)
  • 市場規模の予測値:数量ベース (今後8年間分)
  • 平均価格の動向・予測 (通算15年間分)
  • 市場収益額シェア:流通チャネル別
  • 市場収益額シェア:企業別

第5章 メキシコのニードルフリー注射器市場

第6章 米国のニードルフリー注射器市場

第7章 主要企業の概要:北米のニードルフリー注射器市場

  • INJEX - Equidyne Systems
    • 企業概要
  • Bioject Medical Technologies Inc
  • Antares Pharma Inc
  • PharmaJet Inc
  • MK Global Co.

第8章 ニードルフリー注射器市場のパイプライン製品

第9章 近年の市場動向

  • 企業からの発表 (コーポレート・コミュニケーション) (全14件)
  • 決算発表 (全31件)
  • 政府・公益関連 (全2件)
  • 法令・規制関連 (全2件)
  • その他の主な動き (全2件)

第10章 付録

図表一覧

目次
Product Code: GDMECR0669DB

GlobalData's new report, "North America Needle Free Injections Market Outlook to 2023", provides key market data on the North America Needle Free Injections market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Needle Free Injections.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope:

  • Market size and company share data for Needle Free Injections.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the North America Needle Free Injections market.
  • Key players covered include INJEX - Equidyne Systems, Bioject Medical Technologies Inc and Antares Pharma Inc.

Reasons to buy:

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Needle Free Injections Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Needle Free Injections Market, North America

  • 3.1. Needle Free Injections Market, North America, Revenue ($m), 2009-2023
  • 3.2. Needle Free Injections Market, North America, Revenue ($m), 2009-2016
  • 3.3. Needle Free Injections Market, North America, Revenue ($m), 2016-2023
  • 3.4. Needle Free Injections Market, North America, Volume (Units), 2009-2023
  • 3.5. Needle Free Injections Market, North America, Volume (Units), 2009-2016
  • 3.6. Needle Free Injections Market, North America, Volume (Units), 2016-2023
  • 3.7. Needle Free Injections Market, North America, Company Share by Revenue ($m), 2016

4. Needle Free Injections Market, Canada

  • 4.1. Needle Free Injections Market, Canada, Revenue ($m), 2009-2016
  • 4.2. Needle Free Injections Market, Canada, Revenue ($m), 2016-2023
  • 4.3. Needle Free Injections Market, Canada, Volume (Units), 2009-2016
  • 4.4. Needle Free Injections Market, Canada, Volume (Units), 2016-2023
  • 4.5. Needle Free Injections Market, Canada, Average Price ($), 2009-2023
  • 4.6. Needle Free Injections Market, Canada, Distribution Share by Revenue ($m), 2015-2016
  • 4.7. Needle Free Injections Market, Canada, Company Share by Revenue ($m), 2016

5. Needle Free Injections Market, Mexico

  • 5.1. Needle Free Injections Market, Mexico, Revenue ($m), 2009-2016
  • 5.2. Needle Free Injections Market, Mexico, Revenue ($m), 2016-2023
  • 5.3. Needle Free Injections Market, Mexico, Volume (Units), 2009-2016
  • 5.4. Needle Free Injections Market, Mexico, Volume (Units), 2016-2023
  • 5.5. Needle Free Injections Market, Mexico, Average Price ($), 2009-2023
  • 5.6. Needle Free Injections Market, Mexico, Distribution Share by Revenue ($m), 2015-2016
  • 5.7. Needle Free Injections Market, Mexico, Company Share by Revenue ($m), 2016

6. Needle Free Injections Market, United States

  • 6.1. Needle Free Injections Market, United States, Revenue ($m), 2009-2016
  • 6.2. Needle Free Injections Market, United States, Revenue ($m), 2016-2023
  • 6.3. Needle Free Injections Market, United States, Volume (Units), 2009-2016
  • 6.4. Needle Free Injections Market, United States, Volume (Units), 2016-2023
  • 6.5. Needle Free Injections Market, United States, Average Price ($), 2009-2023
  • 6.6. Needle Free Injections Market, United States, Distribution Share by Revenue ($m), 2015-2016
  • 6.7. Needle Free Injections Market, United States, Company Share by Revenue ($m), 2016

7. Overview of Key Companies in North America Needle Free Injections Market

  • 7.1. INJEX - Equidyne Systems
    • 7.1.1. Company Overview
  • 7.2. Bioject Medical Technologies Inc
    • 7.2.1. Company Overview
  • 7.3. Antares Pharma Inc
    • 7.3.1. Company Overview
  • 7.4. PharmaJet Inc
    • 7.4.1. Company Overview
  • 7.5. MK Global Co.
    • 7.5.1. Company Overview

8. Needle Free Injections Market Pipeline Products

9. Recent Developments

  • 9.1. Corporate Communications
    • 9.1.1. Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board
    • 9.1.2. Jun 06, 2017: Valeritas Appoints Peter J. Devlin to Chairman of its Board of Directors
    • 9.1.3. Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors
    • 9.1.4. Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency
    • 9.1.5. Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board
    • 9.1.6. Jan 05, 2017: Zogenix Announces CFO Transition
    • 9.1.7. Nov 30, 2016: Valeritas Elects Joe Mandato, Ph.D., Experienced Medical Device Executive and Investor, to Board of Directors
    • 9.1.8. Nov 17, 2016: OSE Immunotherapeutics announces the online publication of positive Phase 1 clinical results with FR104 in the Journal of Immunology
    • 9.1.9. Nov 15, 2016: Oncoceutics Presents Abstracts on ONC201 at 2016 American Society of Hematology Meeting
    • 9.1.10. Nov 14, 2016: Olympus VISERA 4K UHD Receives "Excellence in Surgical Products Awards," Minimally Invasive Surgical Product Category
    • 9.1.11. Oct 31, 2016: Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
    • 9.1.12. Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
    • 9.1.13. Sep 22, 2016: Industry Veteran Katherine D. Crothall, PhD to Join Valeritas Board of Directors
    • 9.1.14. Aug 16, 2016: Valeritas Appoints Erick J. Lucera as Chief Financial Officer
  • 9.2. Financial Announcements
    • 9.2.1. May 15, 2017: Aradigm Announces First Quarter 2017 Financial Results
    • 9.2.2. May 12, 2017: Valeritas Reports First Quarter 2017 Financial Results
    • 9.2.3. May 10, 2017: ICU Medical Announces First Quarter 2017 Results
    • 9.2.4. May 09, 2017: Antares Pharma Reports First Quarter 2017 Operating and Financial Results
    • 9.2.5. May 04, 2017: Zogenix Reports First Quarter 2017 Financial Results
    • 9.2.6. May 02, 2017: Merck Announces First-Quarter 2017 Financial Results
    • 9.2.7. Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017
    • 9.2.8. Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017
    • 9.2.9. Mar 28, 2017: Aradigm Announces Fourth Quarter 2016 and Full Year Financial Results
    • 9.2.10. Mar 14, 2017: Antares Pharma Reports Fourth Quarter and Full Year 2016 Operating and Financial Results
    • 9.2.11. Mar 09, 2017: Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results
    • 9.2.12. Mar 01, 2017: ICU Medical Announces Fourth Quarter and Fiscal Year 2016 Results
    • 9.2.13. Feb 21, 2017: Valeritas Reports Fourth Quarter and Full Year 2016 Financial Results
    • 9.2.14. Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
    • 9.2.15. Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results
    • 9.2.16. Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results
    • 9.2.17. Nov 10, 2016: Valeritas Reports Third Quarter 2016 Financial Results
    • 9.2.18. Nov 09, 2016: Antares Pharma Reports Third Quarter 2016 Financial and Operating Results
    • 9.2.19. Nov 09, 2016: Aradigm Announces Third Quarter 2016 Financial Results
    • 9.2.20. Nov 09, 2016: ICU Medical Announces Third Quarter 2016 Results
    • 9.2.21. Nov 08, 2016: Zogenix Provides Corporate Update and Reports Third Quarter 2016 Financial Results
    • 9.2.22. Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016
    • 9.2.23. Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016
    • 9.2.24. Oct 25, 2016: Merck Announces Third-Quarter 2016 Financial Results
    • 9.2.25. Aug 10, 2016: Aradigm Announces Second Quarter 2016 Financial Results
    • 9.2.26. Aug 10, 2016: Valeritas Reports Second Quarter 2016 Financial Results
    • 9.2.27. Aug 09, 2016: Antares Pharma Reports Second Quarter 2016 Operating and Financial Results
    • 9.2.28. Aug 09, 2016: Zogenix Provides Corporate Update and Reports Second Quarter 2016 Financial Results
    • 9.2.29. Aug 08, 2016: ICU Medical Announces Second Quarter 2016 Results
    • 9.2.30. Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016
    • 9.2.31. Jul 26, 2016: Baxter Reports Second Quarter 2016 Results and Raises Financial Outlook for Full-Year 2016
  • 9.3. Government and Public Interest
    • 9.3.1. Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal
    • 9.3.2. Sep 27, 2016: Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy
  • 9.4. Legal And Regulatory
    • 9.4.1. Dec 22, 2016: Teva Pharmaceutical Paying $519 Million to Settle FCPA Charges
    • 9.4.2. Nov 17, 2016: New Data from Global aHUS Registry Presented at ASN 2016 Show a Three-Fold Reduction in Post-Transplant Dialysis in Patients Initiating Soliris (eculizumab) Treatment Prior to Transplant Compared to Initiating Treatment Post-Transplant
  • 9.5. Other Significant Developments
    • 9.5.1. Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
    • 9.5.2. Jan 25, 2017: Daktari Achieves Milestone in Its Merck HCV Collaboration

10. Appendix

  • 10.1. Research Methodology
    • 10.1.1. Coverage
    • 10.1.2. Secondary Research
    • 10.1.3. Primary Research
    • 10.1.4. Company Share Analysis
    • 10.1.5. Distribution Share Analysis
    • 10.1.6. Benchmarking
  • 10.2. GlobalData Consulting
  • 10.3. Contact Us
  • 10.4. Disclaimer

List of Tables

  • Table 1: Needle Free Injections Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2009-2023
  • Table 2: Needle Free Injections Market, North America, Revenue ($m), Historic, USD Constant, 2009-2016
  • Table 3: Needle Free Injections Market, North America, Revenue ($m), Forecast, USD Constant, 2016-2023
  • Table 4: Needle Free Injections Market, North America, Volume (Units), 2009-2023
  • Table 5: Needle Free Injections Market, North America, Volume (Units), Historic, 2009-2016
  • Table 6: Needle Free Injections Market, North America, Volume (Units), Forecast, 2016-2023
  • Table 7: Needle Free Injections Market, North America, Company Share by Revenue ($m), USD Constant, 2016
  • Table 8: Needle Free Injections Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 9: Needle Free Injections Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 10: Needle Free Injections Market, Canada, Volume (Units), Historic, 2009-2016
  • Table 11: Needle Free Injections Market, Canada, Volume (Units), Forecast, 2016-2023
  • Table 12: Needle Free Injections Market, Canada, Average Price ($), Historic, 2009-2016
  • Table 13: Needle Free Injections Market, Canada, Average Price ($), Forecast, 2016-2023
  • Table 14: Needle Free Injections Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 15: Needle Free Injections Market, Canada, Company Share by Revenue ($m), USD Constant, 2016
  • Table 16: Needle Free Injections Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 17: Needle Free Injections Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 18: Needle Free Injections Market, Mexico, Volume (Units), Historic, 2009-2016
  • Table 19: Needle Free Injections Market, Mexico, Volume (Units), Forecast, 2016-2023
  • Table 20: Needle Free Injections Market, Mexico, Average Price ($), Historic, 2009-2016
  • Table 21: Needle Free Injections Market, Mexico, Average Price ($), Forecast, 2016-2023
  • Table 22: Needle Free Injections Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 23: Needle Free Injections Market, Mexico, Company Share by Revenue ($m), USD Constant, 2016
  • Table 24: Needle Free Injections Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 25: Needle Free Injections Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 26: Needle Free Injections Market, United States, Volume (Units), Historic, 2009-2016
  • Table 27: Needle Free Injections Market, United States, Volume (Units), Forecast, 2016-2023
  • Table 28: Needle Free Injections Market, United States, Average Price ($), Historic, 2009-2016
  • Table 29: Needle Free Injections Market, United States, Average Price ($), Forecast, 2016-2023
  • Table 30: Needle Free Injections Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 31: Needle Free Injections Market, United States, Company Share by Revenue ($m), USD Constant, 2016
  • Table 32: Needle Free Injections Market Pipeline Products

List of Figures

  • Figure 1: Needle Free Injections Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2009-2023
  • Figure 2: Needle Free Injections Market, North America, Revenue ($m), Historic, USD Constant, 2009-2016
  • Figure 3: Needle Free Injections Market, North America, Revenue ($m), Forecast, USD Constant, 2016-2023
  • Figure 4: Needle Free Injections Market, North America, Volume (Units), 2009-2023
  • Figure 5: Needle Free Injections Market, North America, Volume (Units), Historic, 2009-2016
  • Figure 6: Needle Free Injections Market, North America, Volume (Units), Forecast, 2016-2023
  • Figure 7: Needle Free Injections Market, North America, Company Share (%) 2016
  • Figure 8: Needle Free Injections Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 9: Needle Free Injections Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 10: Needle Free Injections Market, Canada, Volume (Units), Historic, 2009-2016
  • Figure 11: Needle Free Injections Market, Canada, Volume (Units), Forecast, 2016-2023
  • Figure 12: Needle Free Injections Market, Canada, Company Share (%) 2016
  • Figure 13: Needle Free Injections Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 14: Needle Free Injections Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 15: Needle Free Injections Market, Mexico, Volume (Units), Historic, 2009-2016
  • Figure 16: Needle Free Injections Market, Mexico, Volume (Units), Forecast, 2016-2023
  • Figure 17: Needle Free Injections Market, Mexico, Company Share (%) 2016
  • Figure 18: Needle Free Injections Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 19: Needle Free Injections Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 20: Needle Free Injections Market, United States, Volume (Units), Historic, 2009-2016
  • Figure 21: Needle Free Injections Market, United States, Volume (Units), Forecast, 2016-2023
  • Figure 22: Needle Free Injections Market, United States, Company Share (%) 2016
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.